High Prevalence of Gastrointestinal Manifestations of COVID-19 Infection in Hospitalized Patients With CancerObservational Study Published on 2021-01-012022-10-05 Journal: Journal of clinical gastroenterology [Category] 임상, [키워드] active malignancy anorexia Cancer cancer patient Cancer patients Coronavirus disease-19 COVID-19 diarrhea elevated Elevation evaluated Fever Gastrointestinal GI symptom had no Hospitalized hospitalized COVID-19 patient hospitalized patient initial symptom liver transaminase manifestation Massachusett material multicenter cohort study occur oncology patients Patient patients patients hospitalized Patients with cancer performed predominant presenting Prevalence prevalent reported respiratory symptoms SARS-COV-2 infection severity subset Symptom transaminase vomiting with COVID-19 [DOI] 10.1097/MCG.0000000000001462 PMC 바로가기 [Article Type] Observational Study
Gastrointestinal Manifestations of COVID-19: A Review of What We KnowReviews and Contemporary Updates Published on 2021-01-012022-10-28 Journal: The Ochsner Journal [Category] COVID-19, [키워드] disease transmission–infectious abdominal pain Affect alanine aminotransferase anorexia Aspartate aminotransferase China contribute coronavirus coronavirus disease cough COVID-19 COVID-19 infection diarrhea disease Effect elevated Evidence Fever Gastrointestinal gastrointestinal tract GI symptom GI symptoms GI Tract Gut hepatocellular injury indicated Infection liver liver enzyme manifestation MOST nausea organ pathophysiology Patient patients patients with COVID-19 presenting respiratory symptom respiratory symptoms Respiratory system review RNA SARS-CoV-2 Shortness of breath Stool Transmission virus vomiting with COVID-19 [DOI] 10.31486/toj.20.0086 PMC 바로가기 [Article Type] Reviews and Contemporary Updates
Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut MicrobiotaCellular and Infection Microbiology Published on 2020-12-092022-10-31 Journal: Frontiers in Cellular and Infection Microbiology [Category] COVID-19, MERS, SARS, [키워드] age alteration article articles bacterial specy challenge Clinical course Clinical studies Community Concentration concerning consequence coronavirus COVID-19 COVID-19 infection COVID-19 pandemic COVID-19 severity diabete disorder Dysbiosis Effect effort epidemiological fecal GI symptom Gut gut microbiota Health Human IBS identify Infection infection with SARS-CoV-2 Inflammatory bowel disease initial Intervention intestinal investigated mechanism metabolic disorder Metabolic disorders microbiota nutrition nutritional status obesity required Research researcher risk of infection SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 T2D thought Transmission [DOI] 10.3389/fcimb.2020.575559 PMC 바로가기 [Article Type] Cellular and Infection Microbiology
COVID-19 gastrointestinal manifestations: a systematic reviewMajor Article Published on 2020-11-252022-10-28 Journal: Revista da Sociedade Brasileira de Medicina Tropic [Category] COVID-19, MERS, [키워드] abdominal pain acute respiratory syndrome addition affecting alanine aminotransferase alteration analyzed article Aspartate transaminase Biomarker caused Clinical severity coronavirus coronavirus disease COVID-19 COVID-19 patients digestive disease English Gastrointestinal manifestation Gastrointestinal symptom GI symptom Infection JAMA LILACS Liver function nausea NEJM pandemic Patient patients performed proportion public health reported SARS-CoV-2 SARS-CoV-2-infected individuals SciELO Serum level Spanish Symptom Symptoms systematic review the patient vomiting [DOI] 10.1590/0037-8682-0714-2020 PMC 바로가기 [Article Type] Major Article
Gastrointestinal and hepatic manifestations of COVID ‐19: A systematic review and meta‐analysisOriginal Article Published on 2020-11-212022-10-29 Journal: JGH Open: An Open Access Journal of Gastroenterology and Hepatology [Category] COVID-19, [키워드] 95% CI 95% confidence interval abdominal pain anorexia clinician COVID COVID‐19 COVID‐19 patient COVID‐19 patients COVID‐19 Data collection diarrhea disease Elevation Gastrointestinal GI symptom Isolated Isolation manifestation meta‐analysis Mortality nausea occurred Odds ratio Patient patients performed Prevalence random effect reported resource Result risk of bia SARS‐CoV‐2 searched Symptoms systematic review transaminase vomiting [DOI] 10.1002/jgh3.12456 PMC 바로가기 [Article Type] Original Article
Transaminases are Potential Biomarkers of Disease Severity in COVID-19 Patients: A Single-Center ExperienceInternal Medicine Published on 2020-11-182022-10-31 Journal: Cureus [Category] COVID-19, [키워드] 95% CI acute respiratory syndrome adjusted odds ratio Admission Analysis analyzed Aspartate aminotransferase AST baseline chi-square test clinical implication Comorbidities coronavirus coronavirus disease coronavirus disease-2019 COVID-19 COVID-19 patient COVID-19 patients CRS Cytokine release syndrome elevated experience Gastrointestinal GI symptom hepatic manifestations higher risk Hospitalization identify increased risk Kruskal-Wallis Logistic regression analysis manifestation mechanical ventilation Mortality multivariate outcomes Patient patients with COVID-19 Pearson Potential predictor SARS- CoV2 SARS-CoV2 Spread study groups the median total bilirubin transaminase transaminitis two group variables was performed were used [DOI] 10.7759/cureus.11555 PMC 바로가기 [Article Type] Internal Medicine
Gastrointestinal Symptoms Associated With Unfavorable Prognosis of COVID-19 Patients: A Retrospective StudyMedicine Published on 2020-11-112022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] analyses ARDS ARDS (Acute Respiratory Distress Syndrome) baseline covariates COVID-19 COVID-19 patient COVID-19 patients COX CRRT disease Eligible patients evaluated Gastrointestinal gastrointestinal symptoms GI symptom GI symptoms global pandemic high risk higher risk intubation mechanical ventilation Mortality multivariable Non-invasive occur outcome Patient patients with COVID-19 Probability Prognosis Regression model respiratory symptoms retrospective cohort study risk of death SARS-CoV-2 (COVID-19) single-center stratified survival Symptom the Kaplan-Meier method tracheal Treatment univariable ventilator were used with COVID-19 [DOI] 10.3389/fmed.2020.608259 PMC 바로가기 [Article Type] Medicine
Newly Reported Studies on the Increase in Gastrointestinal Symptom Prevalence withCOVID-19 Infection: A Comprehensive Systematic Review and Meta-AnalysisReview Published on 2020-11-102022-11-01 Journal: Diseases [Category] COVID-19, [키워드] 95%CI abdominal pain anorexia articles available data biopsies Chinese CNKI Comprehensive conducted cough COVID-19 COVID-19 infected patient COVID-19 patients cross diarrhea early stage evaluated Fever Frequency Gastrointestinal Gastrointestinal symptom GI symptom GI symptoms GI Tract Google Scholar heterogeneity identify increase infected with COVID-19 Inpatient medical subject heading Meta-analysis Multiple nausea nausea/vomiting Outpatient outpatients Patient performed Prevalence random effect random effect model reported respiratory symptom review Symptom Symptoms systematic literature search systematic review vomit vomiting was used withCOVID-19 [DOI] 10.3390/diseases8040041 PMC 바로가기 [Article Type] Review
Effects of Ginger on clinical manifestations and paraclinical features of patients with Severe Acute Respiratory Syndrome due to COVID-19: A structured summary of a study protocol for a randomized controlled trialLetter Published on 2020-10-092022-10-29 Journal: Trials [Category] Coronavirus, MERS, SARS, [키워드] 1:1 All study participants allergy antiarrhythmic drug anticipated Arm assigned Bandar Abbas blinded block randomization Breastfeeding C-reactive protein clinical clinical manifestation Clinical symptoms clinical trial Clinicians company Confirmed Control Corticosteroids COVID-19 criteria Critical Department Diagnosis disease Diseases disorder dissemination diuretics dose double-blind dry cough education Effect element Eligible participants exclusion criteria feature Features Fever GI symptom GI symptoms ginger history hypertension incidence Inclusion inhibitor investigator Iran liver lung involvement lymphocytopenia Ministry of Health number Nurses objective outcome parallel group participant Patient patients pharmaceutical placebo tablet placebo-controlled clinical trial Pneumonia polymerase chain Primary outcome protocol randomization Randomized Randomized controlled trial regimen Registered registration date registry renal Research respiratory Sample size SARS-CoV-2 secondary outcome selective Serious Adverse Event serotonin reuptake inhibitor Seven single center standard treatment status Study protocol Tablet therapeutic Thyroid time tiredness treatment arm two group Version web-based system website [DOI] 10.1186/s13063-020-04765-6 PMC 바로가기 [Article Type] Letter
The prevalence of gastrointestinal symptoms among patients with COVID ‐19 and the effect on the severity of the diseaseOriginal Article Published on 2020-09-182022-10-29 Journal: JGH Open: An Open Access Journal of Gastroenterology and Hepatology [Category] COVID-19, [키워드] Affect affected Baghdad city conducted Course COVID COVID‐19 COVID‐19 demographic Gastrointestinal gastrointestinal involvement Gastrointestinal symptom gastrointestinal symptoms gastrointestinal system GI symptom GI symptoms had more highest investigated Iraq laboratory data less manifestation morbidity and mortality Mortality outcome pandemic disease Patient patients polymerase chain Prevalence Prognosis respiratory symptom respiratory symptoms Respiratory system Result retrospective severe disease severity Symptom symptomatic individual the disease the patient World Health Organization [DOI] 10.1002/jgh3.12415 PMC 바로가기 [Article Type] Original Article